rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
6
|
pubmed:dateCreated |
2001-9-14
|
pubmed:abstractText |
The urokinase-dependent activation of plasminogen by breast cancer cells plays an important role in metastasis. We have previously shown that the metastatic breast cancer cell line MDA-MB-231 over-expresses urokinase and binds and efficiently activates plasminogen at the cell surface compared to non-metastatic cells. The aim of this study was to further characterise plasminogen binding and determine the topology of cell surface-bound plasminogen in terms of its potential for activation. The lysine-dependent binding of plasminogen at 4 degrees C to MDA-MB-231 cells was stable and resulted in an activation-susceptible conformation of plasminogen. Topologically, a fraction of bound plasminogen was co-localised with urokinase on the surfaces of MDA-MB-231 cells where it could be activated to plasmin. At 37 degrees C plasmin was rapidly lost from the cell surface. Apart from actin, other candidate plasminogen receptors were either not expressed or did not co-localise with plasminogen at the cell surface. Thus, based on co-localisation with urokinase, plasminogen binding is partitioned into two functional pools on the surface of MDA-MB-231 cells. In conclusion, these results shed further light on the functional organisation of the plasminogen activation cascade on the surface of a metastatic cancer cell.
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/11556845-10190288,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11556845-10389872,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11556845-1991514,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11556845-3023326,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11556845-3880760,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11556845-7593646,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11556845-7851415,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11556845-8239651,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11556845-8710884,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11556845-8857956,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11556845-9003434,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11556845-9083329,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11556845-9635833,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11556845-9665813,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11556845-9888805
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Actins,
http://linkedlifedata.com/resource/pubmed/chemical/Annexin A2,
http://linkedlifedata.com/resource/pubmed/chemical/Fibrinolysin,
http://linkedlifedata.com/resource/pubmed/chemical/PLAUR protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Plasminogen,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Cell Surface,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Urokinase Plasminogen...,
http://linkedlifedata.com/resource/pubmed/chemical/Urokinase-Type Plasminogen Activator
|
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0007-0920
|
pubmed:author |
|
pubmed:copyrightInfo |
Copyright 2001 Cancer Research Campaign http://www.bjcancer.com.
|
pubmed:issnType |
Print
|
pubmed:day |
14
|
pubmed:volume |
85
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
909-16
|
pubmed:dateRevised |
2009-11-19
|
pubmed:meshHeading |
pubmed-meshheading:11556845-Actins,
pubmed-meshheading:11556845-Annexin A2,
pubmed-meshheading:11556845-Breast Neoplasms,
pubmed-meshheading:11556845-Cell Membrane,
pubmed-meshheading:11556845-Fibrinolysin,
pubmed-meshheading:11556845-Flow Cytometry,
pubmed-meshheading:11556845-Humans,
pubmed-meshheading:11556845-Microscopy, Confocal,
pubmed-meshheading:11556845-Neoplasm Metastasis,
pubmed-meshheading:11556845-Plasminogen,
pubmed-meshheading:11556845-Receptors, Cell Surface,
pubmed-meshheading:11556845-Receptors, Urokinase Plasminogen Activator,
pubmed-meshheading:11556845-Tumor Cells, Cultured,
pubmed-meshheading:11556845-Urokinase-Type Plasminogen Activator
|
pubmed:year |
2001
|
pubmed:articleTitle |
The topology of plasminogen binding and activation on the surface of human breast cancer cells.
|
pubmed:affiliation |
Department of Biological Sciences, University of Wollongong, NSW Australia, 2522.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|